Congress is out of session until Monday, November 9 for the midterm campaign. No new roll-call votes until then; the last were the House on Sep 16 and the Senate on Sep 30.

Money / PACs

Bristol-Myers Squibb Company

Corporate PAC FEC C00035675

Influence at a glance · Jan 2025 – Sep 2026Jan 25 – Sep 26 How we count
PAC giving to candidates$345K
Company lobbying, all issues $17.6M

Giving: FEC filings, net of refunds. Lobbying: the company’s own LD-2 reports, all issues, rounded to the nearest $10,000 each quarter. Two different filers, same 21 months.Lobbying: all issues, rounded to the nearest $10,000. Two filers, same 21 months. This PAC gives money raised from the company’s employees; the company itself can’t give to campaigns from its treasury.

Lobbying spend by quarter since 2015Spend by quarter Pro

Free account See Pro

What they lobby on

Method

Bristol-Myers Squibb Company reported federal lobbying in 8 of the last 8 quarters (Q4 2024 to Q3 2026), with its own in-house lobbyists and 14 outside firms. What follows is what the filings say it lobbied on, not which way.

Issue areas ranked by quarters filedQ4 24 → Q3 26

  • Budget/Appropriations8 of 88/8
  • Copyright/Patent/Trademark8 of 88/8
  • Health Issues8 of 88/8
  • Medicare/Medicaid8 of 88/8
  • Pharmacy8 of 88/8
Taxation/Internal Revenue Code 8 of 8 · Trade (domestic/foreign) 8 of 8 · 2 more · Show all 9
  • Taxation/Internal Revenue Code8 of 88/8
  • Trade (domestic/foreign)8 of 88/8
  • Medical/Disease Research/Clinical Labs3 of 83/8
  • Defense1 of 81/8

Bills named in the filings 41 bills, this period

36 more, 20 named in only one filing · Show all 41

From the filings

“Issues related to the 340B Drug Pricing Program - regarding all bio-pharmaceutical related provisions H.R.7635, the 340B PATIENTS Act”
Q3 2026 filing · Medicare/Medicaid
“Access to prescription drugs. Policies related to 340B. Drug Pricing reform/implementation. Food is Medicine initiatives. Issues related to the budget and appropriations process”
Q3 2026 filing · Health Issues

Contacted as listed on the filings

  • U.S. House
  • U.S. Senate
  • Centers For Medicare and Medicaid ServicesCMS
  • Food & Drug AdministrationFDA
  • White House Office
  • Executive Office of the PresidentEOP

The House and Senate appear in every quarter; agencies in all 8 quarters.

Every filing since 2015, with the lobbyists named and the quarters each bill appearsEvery filing since 2015 Pro

Free account See Pro

Source: Lobbying Disclosure Act filings (LD-2) by Bristol-Myers Squibb Company, Senate Office of Public Records. Filings are due 20 days after each quarter ends.

From FEC filings: direct gifts this PAC reported, net of refunds · How we count

Gave directly to 112 sitting members of Congress and 3 other candidates in 2025–26.

Everyone this PAC fundsPro

See every candidate and member Bristol-Myers Squibb Company gave to directly, how much, and how its money splits between the parties.

This part is in Pro. A free account lets you follow up to 3 people and get a weekly email about them; upgrade whenever you need more.

Create a free account See what Pro adds Log in